vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 19.45 USD -2.7% Market Closed
Market Cap: 62m USD

Intrinsic Value

The intrinsic value of one VTVT stock under the Base Case scenario is 7.01 USD. Compared to the current market price of 19.45 USD, vTv Therapeutics Inc is Overvalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VTVT Intrinsic Value
7.01 USD
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
vTv Therapeutics Inc

Valuation History Unavailable

Historical valuation for VTVT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about vTv Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
vTv Therapeutics Inc

Current Assets 38.1m
Cash & Short-Term Investments 36.7m
Receivables 62k
Other Current Assets 1.3m
Non-Current Assets 153k
PP&E 153k
Efficiency

Free Cash Flow Analysis
vTv Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
vTv Therapeutics Inc

Revenue
1m USD
Operating Expenses
-25.2m USD
Operating Income
-24.2m USD
Other Expenses
5.7m USD
Net Income
-18.5m USD
Fundamental Scores

VTVT Profitability Score
Profitability Due Diligence

vTv Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROE
Exceptional ROIC
ROE is Increasing
40/100
Profitability
Score

vTv Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

VTVT Solvency Score
Solvency Due Diligence

vTv Therapeutics Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
44/100
Solvency
Score

vTv Therapeutics Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

Wall Street analysts forecast VTVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTVT is 36.21 USD with a low forecast of 35.35 USD and a high forecast of 37.8 USD.

Lowest
Price Target
35.35 USD
82% Upside
Average
Price Target
36.21 USD
86% Upside
Highest
Price Target
37.8 USD
94% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

vTv Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VTVT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VTVT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VTVT stock?

The intrinsic value of one VTVT stock under the Base Case scenario is 7.01 USD.

Is VTVT stock undervalued or overvalued?

Compared to the current market price of 19.45 USD, vTv Therapeutics Inc is Overvalued by 64%.

Back to Top